Skip to main content
. 2019 May 24;28(6):1779–1784. doi: 10.1007/s10068-019-00627-3

Fig. 3.

Fig. 3

Scatter-plot of symptoms sum-score of respiratory symptoms (rhinorrhea, nose congestion, sneezing and asthma) throughout the study period of 8 weeks. Oral supplementation of DAO from visit 1 to visit 3 (V1 to V3); no oral DAO from visit 3 to visit 5 (V3 to V5)